正在加载视频...

视频加载失败

Machina Labs Technologies and sheet metal manufacturing capabilities including roboforming (tm), trimming, drilling, scanning, and more. Video Credit: Machina Labs hashtag#engineering hashtag#technology

142,292 次观看 • 2 个月前 •via X (Twitter)

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频

ICYMI: Brains are trending.. OpenAI made a direct investment into Merge Labs' $252M Seed at $850M valuation Merge Labs Labs is a Brain-Computer Interface ("BCI") research lab co-founded by Sam Altman, Alex Blania, & key frontier tech leaders (below) with expertise in neuroscience, bioengineering, hardware, AI systems, & foundational research. Unlike Elon Musk's Neuralink, which utilizes surgical implants, Merge Labs is developing non-invasive, high-bandwidth brain-computer interfaces (BCIs). The company uses a combination of ultrasound, AI-driven signal interpretation, and potentially genetic engineering to read neural activity without surgery. Founding Team: Alex Blania (Alex Blania) – Co-founder of World, an Altman-co-founded digital proof of human protocol; co-founder of Merge Labs. Sam Altman (Sam Altman) – CEO of OpenAI; co-founder of Merge Labs participating in a personal capacity. Altman has been reported as likely to serve in a strategic role but not in day-to-day operational management of Merge Labs. Mikhail Shapiro (Mikhail Shapiro (same on bsky)) – Professor of Chemical and Medical Engineering at Caltech and founding scientific leader for Merge Labs. He has also served as an adviser to Forest Neurotech. Sumner Norman (Sumner L Norman) – CEO of Forest Neurotech, a nonprofit research organization focused on ultrasound-based brain-computer interface technologies; also a co-founder of Merge Labs. Sandro Herbig (Sandro Herbig) – Identified as a technology entrepreneur and co-founder of Merge Labs with prior systems and product experience, including work with Blania on Tools for Humanity and World. While specific current corporate title at Merge hasn’t been publicly detailed, he is recognized as part of the founding leadership team. Tyson Aflalo – Chief Scientific Officer of Forest Neurotech prior to Merge Labs; co-founder and technical lead at Merge Labs with expertise in neural engineering and ultrasound BCI research. . . . "It’s a direct investment from OpenAI, not their venture arm, so it’s an actual collaboration. As we were discussing the investment, there were many different dimensions where collaboration could make sense. One area is protein design. We’re working extensively with proteins, and that’s an area that’s broadly interesting to OpenAI. It’s one of the most compelling applications of AI — for example, the work Google did with AlphaFold. More broadly, AI has significant implications for biology and for accelerating that part of what we’re building. Another area is chips. Eventually, once we have a clear scientific understanding of what we’re building and how it will work, a major focus for many years will be on making these chips highly energy efficient."

Molly O’Shea

38,842 次观看 • 6 个月前